NZ184893A - Pure crystalline form of cimetidine a(n-methyl-n-cyano-n-(-2-(5-methyl-4imidazolyl) methylthio) ethyl)-guanidine andpharmaceutical compositions containing it - Google Patents

Pure crystalline form of cimetidine a(n-methyl-n-cyano-n-(-2-(5-methyl-4imidazolyl) methylthio) ethyl)-guanidine andpharmaceutical compositions containing it

Info

Publication number
NZ184893A
NZ184893A NZ184893A NZ18489377A NZ184893A NZ 184893 A NZ184893 A NZ 184893A NZ 184893 A NZ184893 A NZ 184893A NZ 18489377 A NZ18489377 A NZ 18489377A NZ 184893 A NZ184893 A NZ 184893A
Authority
NZ
New Zealand
Prior art keywords
methyl
cimetidine
methylthio
guanidine
cyano
Prior art date
Application number
NZ184893A
Other languages
English (en)
Inventor
G D Tovey
P M G Bavin
R J Ward
J C P Sly
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB3906576A external-priority patent/GB1543238A/en
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of NZ184893A publication Critical patent/NZ184893A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NZ184893A 1976-09-21 1977-08-10 Pure crystalline form of cimetidine a(n-methyl-n-cyano-n-(-2-(5-methyl-4imidazolyl) methylthio) ethyl)-guanidine andpharmaceutical compositions containing it NZ184893A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3906576A GB1543238A (en) 1976-09-21 1976-09-21 Polymorph of cimetidine
GB271677 1977-01-24

Publications (1)

Publication Number Publication Date
NZ184893A true NZ184893A (en) 1980-11-28

Family

ID=26237687

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ184893A NZ184893A (en) 1976-09-21 1977-08-10 Pure crystalline form of cimetidine a(n-methyl-n-cyano-n-(-2-(5-methyl-4imidazolyl) methylthio) ethyl)-guanidine andpharmaceutical compositions containing it

Country Status (10)

Country Link
JP (1) JPS5340771A (xx)
AU (1) AU510629B2 (xx)
BE (1) BE858432A (xx)
CA (1) CA1096387A (xx)
DE (1) DE2742531A1 (xx)
FR (1) FR2364906A1 (xx)
IE (1) IE45873B1 (xx)
IL (1) IL52784A (xx)
LU (1) LU78142A1 (xx)
NZ (1) NZ184893A (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56104868A (en) * 1980-01-24 1981-08-20 Fujimoto Seiyaku Kk Conversion between polymorphous crystals of cimetidine
JPS56164122A (en) * 1980-05-21 1981-12-17 Fujimoto Seiyaku Kk Drug composition comprising cimetidine as main agent
HU185636B (en) * 1981-06-26 1985-03-28 Richter Gedeon Vegyeszet Process for preparing new cimetidine-hydrate /cimetidine-h/
HU185457B (en) * 1981-09-25 1985-02-28 Richter Gedeon Vegyeszet Process for preparating cimetidine-z
JPS5888366A (ja) * 1981-11-19 1983-05-26 Fujimoto Seiyaku Kk グアニジン誘導体の製造法
JPS59128375A (ja) * 1983-01-10 1984-07-24 Tokawa Tetsuo イミダゾ−ル系化合物の製法
JPS59130273A (ja) * 1983-01-14 1984-07-26 Tokawa Tetsuo イミダゾ−ル系化合物の製造法
JPS59130274A (ja) * 1983-01-14 1984-07-26 Tokawa Tetsuo イミダゾ−ル系化合物の製法
HU196184B (en) * 1986-09-11 1988-10-28 Richter Gedeon Vegyeszet Process for producing cimetidine-a modification

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1397436A (en) * 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines
GB1531231A (en) * 1974-09-02 1978-11-08 Smith Kline French Lab Process for the production of cyanoguanidine derivatives
GB1533380A (en) * 1974-09-02 1978-11-22 Smith Kline French Lab Process for the preparation of heterocyclic substituted thioureas and h-cyanoguanidines
PT65369B (en) * 1975-08-20 1978-01-10 Smithkline Corp Reduction process

Also Published As

Publication number Publication date
IL52784A (en) 1980-09-16
AU510629B2 (en) 1980-07-03
FR2364906A1 (fr) 1978-04-14
BE858432A (fr) 1978-03-06
IE45873L (en) 1978-07-24
IE45873B1 (en) 1982-12-15
IL52784A0 (en) 1977-10-31
LU78142A1 (xx) 1978-01-17
DE2742531A1 (de) 1978-03-23
JPS6222967B2 (xx) 1987-05-20
CA1096387A (en) 1981-02-24
JPS5340771A (en) 1978-04-13
AU2879277A (en) 1979-03-22

Similar Documents

Publication Publication Date Title
GB2011967B (en) Compositions containing silicon compounds
JPS5388022A (en) Manufacture of bitumennpolymer compound
CU21105A (es) Compuestos polienicos
IL54571A0 (en) Growth promoting compositions containing certain triazine derivatives
JPS5727916A (en) Manufacture of a type crystalline zeolite powder
NZ192851A (en) Anticoccidial compositions carbanilide derivatives
IL52765A (en) Pesticidal compositions comprising triazine derivatives and some novel compounds of this type
AU525989B2 (en) Compositions containing pyridinethione salts andn-acetylcysteine
JPS5761619A (en) Manufacture of a type crystalline zeolite powder
JPS5727918A (en) Manufacture of a type crystalline zeolite powder
IL47803A0 (en) Herbicidal compositions containing substituted pyrimidine derivatives
IL55043A (en) Phytobactericidal compositions containing 6-fluoro-4-oxoquinole-3-carboxylic acid derivatives and some new such compounds
JPS5761620A (en) Manufacture of a type crystalline zeolite powder
NZ184893A (en) Pure crystalline form of cimetidine a(n-methyl-n-cyano-n-(-2-(5-methyl-4imidazolyl) methylthio) ethyl)-guanidine andpharmaceutical compositions containing it
JPS5727919A (en) Manufacture of a type crystalline zeolite powder
JPS52154581A (en) Stabilization of compound
GR59263B (en) Compositions based on alcenylouceinimides derivatives of n,n,n',n'tetrakis(amino-3propyl)ethylenediamine
JPS5331626A (en) Preparation of siliconnnitrogen compound
GB2090136B (en) Antiviral compositions containing sulphonamide derivatives
JPS5414974A (en) Novel radiationnphotosensitive compound and radiationnphotosensitive compositions containing same
IL53767A0 (en) Anthelmintic compositions containing certain malononitrille derivatives
JPS52139155A (en) Compositions of high molecular compounds stabilized
AU2863977A (en) Fungicidal compositions of 6-flurondole
JPS5727917A (en) Manufacture of a type crystalline zeolite powder
IL54351A (en) Symmetrical(bis-carbamoyloxime)disulfide compounds and pesticidal compositions containing the same